![](https://sp-ao.shortpixel.ai/client/to_auto,q_glossy,ret_img,w_800,h_567/https://readof.com/wp-content/uploads/2021/07/expert-panel-says-new-56k-alzheimers-drug-is-unproven-and-worth-8400-max.jpg)
Skilled panel says new $56Okay Alzheimer’s drug is unproven—and price $8,400 max
Enlarge / The outside of the headquarters of biotechnology firm Biogen in Cambridge, Massachusetts. (credit score: Getty | Boston Globe) Biogen’s new Alzheimer’s drug Aduhelm continues to face opposition after its contentious approval by the Meals and Drug Administration final